Related Post
Published by the European Respiratory Society European Respiratory Society, ERS Statement regarding Philip Morris International’s purchase of Victora, a manufacturer of inhalers for the treatment of asthma and lung disease.
The most important products of Philip Morris
And she said in the statement: The European Respiratory Society feels (ERS) Seriously concerned about the proposed acquisition of VictorVectura by the tobacco company Philip Morris International (PMI).
She added, “This news is very disappointing for the hard-working scientists at Victora Vectura , who have dedicated their careers to developing products that improve the quality of life for people with debilitating lung disease, and all those who advocate for tobacco control, arguing that tobacco is one of the biggest causes of lung disease that can be prevented by stopping smoking..
European Respiratory Society
She explained that the tobacco industry is responsible for the suffering and premature death of millions of people around the world every year, so it is extremely unethical for a tobacco company to profit from people’s addiction to its highly harmful products, and then later seek to increase profits from the drugs produced to treat the harm caused by its products. Emphasizing that it is deeply concerned that the proposed transaction will enable Philip Morris InternationalPMI from masking its image as a company that benefits from getting people addicted to its dangerous products, and that the tobacco company will be in a position to abuse the inhalation techniques developed by Victora Vectura To make tobacco products more addictive, explaining that if Philip Morris International (PMI) You really want to bypass “nicotine”, you should focus on stopping the promotion and mass selling of all tobacco products without delay.
The European Respiratory Society said that it has strict rules and other medical institutions against the participation of individuals and companies associated with the tobacco industry in the activities of the association, including membership, participation in events and participation in research activities, due to conflicts of interest, explaining that it is also possible that the deal will be harmful. material for victora company VecturaHealth professionals will avoid prescribing drugs from any company that enriches the tobacco industry due to the ethical implications.
Under the European Respiratory Society ERS Strongly Victor shareholder Vectura On rejecting the deal to ensure the continuation of the company’s scientists Vectura In communicating with the scientific community to the fullest extent, to protect the safety of its essential medical products, and to prevent the misuse of its technologies by the tobacco industry, adding that if the acquisition is approved by the shareholders, the European Respiratory Society ERS s
UK authorities are calling for them to use their power to interfere with the deal in order to protect public health and public confidence in essential medical supply chains.
Recall that the site CNN Al-Khabar newspaper, published a report yesterday, confirming that the giant cigarette company Philip Morris, Philip Morris International , taking control of the Victora factory Vectura The British specialist in the manufacture of inhalers, in Britain, despite the objections of health care associations.
For his part, Dr. Essam El-Maghazi, a consultant in chest diseases and president of the Anti-Smoking, Tuberculosis and Chest Diseases Association, criticized the Philip Morris company’s acquisition of the most important factory for the production of inhalers in the world, stressing that this step leads to mixing papers between the most important source of chest diseases, and the purchase of the most important product for inhalers, explaining It may be that its goal is to whiten the face of the tobacco companies
He added, that if its goal is noble, it should stop producing tobacco of all kinds, whether traditional or heated, but we find that its sales of traditional cigarettes are still high in all countries, including Egypt, stressing that scientists should pay attention to the devious ways that cigarette companies resort to, And not to participate in their research in the Victora factory, which it is trying to acquire, and the important question is how the company that produces the largest product that causes chest diseases acquires the factory that provides the most important inhalers for the treatment of chest diseases??.
